AOP Orphan Pharmaceuticals Aktiengesellschaft
AOP Orphan Pharmaceuticals Aktiengesellschaft
Contact:
AOP
Phone: +43 503 72 44 24
E-Mail: nina.roth@aoporphan.com
KEYWORDS:
  • ???????????????
  • 2020??????BESREMi®
  • ?????????????
attachments to announcement
AOP Orphan announces 5-year results on BESREMi® (Ropeginterferon alfa-2b) in PV at the ASH Annual Meeting 2020
back to announcement
PDFs
AOP Orphan Pharmaceuticals announces
[ download PDF ]
title: AOP Orphan Pharmaceuticals announces
image text: 5-years results on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) Annual Meeting 2020
copyright: AOP Orphan